
Barts Health researchers show nasal spray can prevent Covid-19
Newly published results from a clinical trial led by Barts Health and Queen Mary University of London researchers show that a nasal spray (pHOXWELL) can reduce infection with SARS-CoV-2 (the virus that causes Covid-19) by 62%. The trial was carried out in India between April to July 2021, the peak surge of the highly infectious Delta variant. It involved 556 participants...